2019³â Á¦ 14Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ : 2019-03-22±³À°ÀÏÀÚ : 2019-03-22
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2019³â Á¦ 14Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ
´ã´çÀÚ : ÀÌ¿µ¼ö
¿¬¶ôó : 02-2258-7472
À̸ÞÀÏ :
office@korvac.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ȸ¿ø »çÀüµî·Ï µî±Þº° 3¸¸¿ø, 5¸¸¿ø, ºñȸ¿ø »çÀüµî·Ï 8¸¸¿ø ȸ¿ø ÇöÀåµî·Ï µî±Þº° 5¸¸¿ø, 7¸¸¿ø, ºñȸ¿ø ÇöÀåµî·Ï 10¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 08:40~09:00 Opening °ÁøÇÑ(°¡Å縯´ë ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 09:00~09:25 HPV vaccination in boys and men ±èµ¿Çö(ÀÎÇÏ´ë ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 09:25~09:50 Effectiveness of varicella vaccine in Korean children ±èÀ±°æ(°í·Á´ë ¼Ò¾Æû¼Ò³â°ú)
Åä·Ð 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 09:50~10:00 Q & A ¿ìÁØÈñ(¿ï»ê´ë °¨¿°³»°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 10:00~10:25 Fish vaccination in aquaculture Á¤Å¼º(°æ»ó´ë ¼öÀÇ°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 10:25~10:50 Up-date of Foot-and-mouth disease vaccine use in Korea ¹ÚÁ¾Çö(³ó¸²Ãà»ê°Ë¿ªº»ºÎ)
Åä·Ð 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 10:50~11:00 Q & A À¯ÇÑ»ó(¼¿ï´ë ¼öÀÇÇаú)
ÈÞ½Ä 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 11:00~11:15 Coffee break ()
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 11:15~11:45 State of Art lecture : Future of vaccine development ¼º¹é¸°(¿¬¼¼´ë »ý¸í°øÇаú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 11:45~12:10 Moving towards next-generation TB vaccine development : Challenges and Opportunities ½Å¼ºÀç(¿¬¼¼´ë ¹Ì»ý¹°Çб³½Ç)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 12:10~12:35 Medical significance of IL-15-induced T cell activation ½ÅÀÇö(KAIST ÀÇ°ú´ëÇпø)
Åä·Ð 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 12:35~12:45 Q & A ¹è¿ë¼ö(¼º±Õ°ü´ë »ý¸í°úÇаú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 12:45~13:40 Live oral typhoid vaccine Juan J Barriga(PaxVax)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 13:40~14:05 Q fever in Human in Korea ÇãÁß¿¬(¾ÆÁÖ´ë °¨¿°³»°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 14:05~14:30 SFTS in Korea ±èµ¿¹Î(Á¶¼±´ë °¨¿°³»°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 14:30~14:55 2019 measle outbreak in Daegu city - focused on hospital responsiveness ÀåÇöÇÏ(°æºÏ´ë °¨¿°³»°ú)
Åä·Ð 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 14:55~15:05 Q & A ȲÀÀ¼ö(¼¿ï´ë ¹Ì»ý¹°Çб³½Ç)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 15:05~15:35 Measles Elimination: Using Outbreaks to Identify and Close Immunity Gaps ¾çžð(WHO Lao PDR Country Office)
ÈÞ½Ä 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 15:35~15:50 Coffee break ()
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 15:50~16:15 Prerequisites for evidence-based NIP ÃÖ¿ø¼®(°í·Á´ë °¨¿°³»°ú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 16:15~16:40 National seroprevalence study of VPD Á¤°æÅÂ(Áúº´°ü¸®º»ºÎ °¨¿°º´¿¬±¸¼¾ÅÍ)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 16:40~17:05 Role of health economics & financing on vaccine introduction in NIP ¾ÈÁ¤ÈÆ(ÀÌÈ¿©´ë À¶ÇÕº¸°ÇÇаú)
±³À°½Ã°£ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 17:05~17:30 post-registration safety monitoring system Á¤¼±¿µ(Áß¾Ó´ë ¾àÇаú)
Åä·Ð 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 17:30~17:40 Q & A ¿À¸íµ·(¼¿ï´ë °¨¿°³»°ú)
±âŸ 03-22 °¡Å縯´ëÇб³ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø 2Ãþ ´ë°´ç 17:40~17:50 Closing ±è¿ìÁÖ(°í·Á´ë °¨¿°³»°ú)